Medical Digest & Congress Report

Dr. Victoria Werth provides an expert analysis of the EULAR 2026 session exploring the role of Toll-like receptor 7 and 8 (TLR7/8) inhibition in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). This recap looks beneath the surface at the underlying pathogenic mechanisms of the disease, highlighting the latest clinical data and new therapeutic perspectives on how targetin...

Dr. Marco Gattorno provides an essential overview of the EULAR 2026 session focused on the transition of young patients with autoinflammatory diseases from pediatric to adult rheumatology care. This recap highlights the practical and clinical implications for daily medical management, emphasizing the need for structured multidisciplinary protocols. The discussion explores how to maintain treatment...

Professor Ruxandra Ionescu delivers an expert overview of the EULAR 2026 session dedicated to the advanced management of Rheumatoid Arthritis. This comprehensive recap explores the latest clinical evidence, emerging therapeutic pathways, and refined treat-to-target protocols designed to address complex, difficult-to-treat cases. The discussion highlights practical strategies for optimizing long-te...

Dr. Elena Elefante provides an expert look into the EULAR 2026 joint session "Tired is not just a state of mind," focusing on the clinical realities of pathological fatigue in patients with rheumatic and musculoskeletal diseases (RMDs). This overview dives into how chronic fatigue is increasingly recognized as a complex biological symptom rather than a purely psychological state. The rec...

Dr. Michael Zauner provides a comprehensive expert overview of the latest advancements in assessing disease activity in Psoriatic Arthritis, presented at the EULAR 2026 Congress. This recap explores the evolving role of multi-domain assessment tools, the integration of patient-reported outcomes, and how more precise tracking measures are shaping modern treat-to-target strategies to improve long-te...

Dr. Carel le Roux delivers an expert overview of the highly anticipated findings from the SYNCHRONIZE™ Phase 3 clinical studies, presented at the ADA Scientific Sessions. The discussion focuses on the clinical benefits of glucagon/GLP-1 receptor dual agonism, showcasing new data on survodutide. This recap highlights how targeting both pathways offers a powerful approach to weight management and me...

Dr. Joshua Brody provides an expert overview of the most impactful clinical updates and essential takeaways from the 2026 ASCO Annual Meeting, focusing on groundbreaking advancements in lymphoma care. The recap explores the latest data on bispecific antibodies, including remarkable complete remission rates in Mantle Cell Lymphoma, crucial safety updates for outpatient administration, and the rapid...

Professor Giampaolo Bianchini discusses the evolving landscape of immunotherapy in early-stage breast cancer, focusing on predictive biomarkers, patient selection, and the integration of checkpoint inhibitors into neoadjuvant and adjuvant treatment settings to improve long-term outcomes. Video: https://medicaldigest.org/scientific-contents/interview:immunotherapy-early-stage-breast-cancer-report-e...

Professor Hope S. Rugo discusses the final overall survival results from the Phase 3 CAPItello-291 trial, evaluating the efficacy, long-term disease control, and safety of combining the AKT inhibitor capivasertib with fulvestrant for patients with AI-resistant, HR+/HER2− advanced breast cancer. Video: https://medicaldigest.org/scientific-contents/interview:capitello-291-trial-final-overall-surviva...

Professor Meryam Schouler-Ocak provides an expert overview of the most impactful discussions, clinical updates, and essential takeaways from the 2026 EPA Congress, exploring the latest advancements and future directions in psychiatric research and practice. Video: https://medicaldigest.org/scientific-contents/interview:highlights-and-key-takeaways-2026-epa-congress

Professor Mardi Gomberg-Maitland presents the results from the Phase 2 CADENCE trial, investigating the efficacy and safety of Sotatercept in patients with combined post- and pre-capillary pulmonary hypertension associated with heart failure with preserved ejection fraction (HFpEF). Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-sotatercept-ph-hfpef-results-phas...

Professor Geoffrey D. Barnes examines the therapeutic innovations introduced in the new ACC 2026 Acute Pulmonary Embolism Guideline, focusing on updated treatment protocols and novel anticoagulation strategies presented at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:therapeutic-novelties-new-acc-2026-acute-pulmonary-embolism-guideline

Dr. Stephen Thomas examines the evolving role of human challenge models in vaccine development, debating whether they represent a new gold standard for establishing efficacy and safety at the World Vaccine Congress Washington 2026. Video: https://medicaldigest.org/scientific-contents/interview:human-challenge-models-new-gold-standard

Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune adverse events following immunization (AEFI) at the World Vaccine Congress Washington 2026. Video: https://medicaldigest.org/scientific-contents/interview:insis-metacohort-vaccine-safety-study-paradigm-clinical-and-immune-aefi-profiling

Dr. Yurong Fei-Bloom explores the essential strategies for fostering public confidence in immunization by prioritizing transparency and leveraging technological advancements at the World Vaccine Congress Washington 2026. Video: https://medicaldigest.org/scientific-contents/interview:building-future-vaccine-trust-through-transparency-and-innovation

Dr. Richard Hughes IV examines the shifting landscape of immunization mandates and public health legislation, questioning whether the heightened demand for safety proof is becoming the new standard for vaccine policy at the World Vaccine Congress Washington 2026. Video: https://medicaldigest.org/scientific-contents/interview:prove-its-safe-new-vaccine-policy-norm

Dr. Bill Hausdorff explores the complex dynamics of combining respiratory vaccines, focusing on how to optimize clinical efficacy and long-term durability while streamlining complex immunization schedules at the World Vaccine Congress Washington 2026. Video: https://medicaldigest.org/scientific-contents/interview:combining-respiratory-vaccines-balancing-efficacy-durability-and-immunization-schedul...

Professor Joo-Yong Hahn presents critical insights on the discontinuation of beta-blocker therapy in stabilized patients following an acute myocardial infarction, discussing the clinical implications and trial findings at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:discontinuation-b-blocker-therapy-stabilized-patients-after-acute-myocardial-infarcti...

Professor Daniel Jones joins a panel of distinguished specialists to provide expert commentary on the 2025 High Blood Pressure Guideline, focusing on evidence-based strategies for clinical implementation at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:2025-high-blood-pressure-guideline

Professor Gregory Piazza provides an expert overview of the newly released 2026 Acute Pulmonary Embolism Guideline, focusing on critical updates in diagnosis and management at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:acute-pulmonary-embolism-guideline-2026

Professor Keith C. Ferdinand joins a panel of experts to discuss the practical implementation and clinical implications of the 2025 High Blood Pressure Guideline at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:meet-experts-2025-high-blood-pressure-guideline

Dr. Luke Laffin presents the results of the Kardinal Phase 2 study, investigating the efficacy of Tonlamarsen as a novel treatment option for patients with uncontrolled hypertension at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:kardinal-phase-2-study-tonlamarsen-treatment-uncontrolled-hypertension

Prof. Stanislav Henkin and Prof. Daniella Kadian-Dodov lead a comprehensive, case-based exploration of pulmonary embolism management in 2026, tracking the patient journey from initial diagnosis through to long-term recovery strategies at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:pulmonary-embolism-2026-case-based-journey-diagnosis-recovery

Professor Joseph William Rossano presents the highly anticipated results from the Phase 3 Scout-HCM trial, evaluating the efficacy and safety of Mavacamten in symptomatic adolescent patients living with obstructive hypertrophic cardiomyopathy at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:mavacamten-symptomatic-adolescent-patients-obstructive-hcm-re...

Professor Roxana Mehran addresses the critical need for gender-specific approaches in cardiovascular care, discussing strategies and clinical advancements aimed at saving women's hearts at the ACC 2026 Annual Congress. Video: https://medicaldigest.org/scientific-contents/interview:saving-womens-hearts